Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influcid in feverish upper respiratory tract infections
ISRCTN60440500Phase 4Completed
- Sponsor
- Deutsche Homöopathie-Union
- Start
- Nov 2010
01
Overview
Phase 4, randomised, open-label trial of Influcid in upper respiratory infection (URI) (2 arms), sponsored by Deutsche Homöopathie-Union. Primary endpoints: Fever measurement and WURSS-21 symptom assessment. Started Nov 2010; status: completed.
02
Drugs
Influcid
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ISRCTN60440500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN60440500.